4-carbamoylimidazolium 5-olate has been researched along with Myeloproliferative Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katayama, N; Kobayashi, T; Minami, N; Morita, K; Mukai, K; Nishikawa, M; Sekine, T; Takeda, M; Tamaki, S; Tanaka, H | 1 |
1 trial(s) available for 4-carbamoylimidazolium 5-olate and Myeloproliferative Disorders
| Article | Year |
|---|---|
[Clinical trial of SM-108 in myeloproliferative disorders].
Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Imidazoles; Leukemia, Myeloid; Male; Middle Aged; Myeloproliferative Disorders; Thrombocythemia, Essential | 1987 |